|
2005 Journal Article Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarctionNikolsky, E, Sadeghi, HM, Effron, MB, Mehran, R, Lansky, AJ, Na, YB, Cox, DA, Garcia, E, Tcheng, JE, Griffin, JJ, Stuckey, TD, Turco, M, Carroll, JD, Grines, CL and Stone, GW (2005). Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. American Journal of Cardiology, 96 (4), 474-481. doi: 10.1016/j.amjcard.2005.04.005 |
|
2004 Journal Article Final results of the ReoPro Readministration RegistryDery, JP, Braden, GA, Lincoff, AM, Kereiakes, DJ, Browne, K, Little, T, George, BS, Sane, DC, Cines, DB, Effron, MB, Mascelli, MA, Langrall, MA, Damaraju, L, Barnathan, ES and Tcheng, JE (2004). Final results of the ReoPro Readministration Registry. American Journal of Cardiology, 93 (8), 979-984. doi: 10.1016/j.amjcard.2003.12.051 |
|
2003 Journal Article Feasibility and implications of an early discharge strategy after percutaneous intervention with Abciximab in acute myocardial infarction (the CADILLAC trial)Kandzari, DE, Tcheng, JE, Cohen, DJ, Bakhai, A, Grines, CL, Cox, DA, Effron, M, Stuckey, T, Griffin, JJ, Turco, M, Carroll, JD, Fahy, M, Mehran, R and Stone, GW (2003). Feasibility and implications of an early discharge strategy after percutaneous intervention with Abciximab in acute myocardial infarction (the CADILLAC trial). American Journal of Cardiology, 92 (7), 779-784. doi: 10.1016/S0002-9149(03)00882-8 |
|
2003 Journal Article Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction - The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialTcheng, JE, Kandzari, DE, Grines, CL, Cox, DA, Effron, MB, Garcia, E, Griffin, JJ, Guagliumi, G, Stuckey, T, Turco, M, Fahy, M, Lansky, AJ, Mehran, R and Stone, GW (2003). Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction - The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation, 108 (11), 1316-1323. doi: 10.1161/01.CIR.0000087601.45803.86 |
|
2000 Journal Article Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: Ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventionsKleiman, NS, Grazeiadei, N, Maresh, K, Taylor, RJ, Frederick, B, Lance, ET, Effron, MB, Jordan, RE and Mascelli, MA (2000). Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: Ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions. American Heart Journal, 140 (3), 492-501. doi: 10.1067/mhj.2000.109220 |
|
2000 Journal Article Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trialsLincoff, AM, LeNarz, LA, Despotis, GJ, Smith, PK, Booth, JE, Raymond, RE, Sapp, SK, Cabot, CF, Tcheng, JE, Califf, RM, Effron, MB and Topol, EJ (2000). Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials. Annals of Thoracic Surgery, 70 (2), 516-526. doi: 10.1016/S0003-4975(00)01343-6 |
|
2000 Journal Article Effects of abciximab, ticlopidine, and combined abciximab/ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplastyFredrickson, BJ, Turner, NA, Kleiman, NS, Graziadei, N, Maresh, K, Mascelli, MA, Effron, MB and McIntire, LV (2000). Effects of abciximab, ticlopidine, and combined abciximab/ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty. Circulation, 101 (10), 1122-1129. doi: 10.1161/01.CIR.101.10.1122 |
|
2000 Journal Article Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patientsMak, KH, Effron, MB and Moliterno, DJ (2000). Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients. Drugs & Aging, 16 (3), 179-187. doi: 10.2165/00002512-200016030-00003 |
|
1999 Journal Article Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: Results of ReoMI pilot studyMakkar, R, Goff, B, Eigler, N, Sebastian, M, Fischell, T, Barr, L, D'Haem, C, Shah, PK, Effron, MB and Litvack, F (1999). Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: Results of ReoMI pilot study. Catheterization and Cardiovascular Interventions, 48 (4), 430-434. doi: 10.1002/(SICI)1522-726X(199912)48:43.0.CO;2-G |
|
1999 Journal Article Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplastyBrener, SJ, Barr, LA, Burchenal, JEB, Wolski, KE, Effron, MB and Topol, EJ (1999). Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. American Journal of Cardiology, 84 (6), 728-+. doi: 10.1016/S0002-9149(99)00421-X |
|
1999 Journal Article Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study)Ellis, SG, Effron, MB, Gold, HK, Leon, MB, Popma, JJ, Serruys, PWJC, Colombo, A, Cohen, N, Juran, N, Werner, W, Heuser, RR, Spooner, S, Rihal, CS, Fox, R, Leon, MB, Brennan, J, Ricci, D, Fox, R, Teirstein, PS, Norman, S, Morris, N, Zidar, J and Rund, M (1999). Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). Circulation, 100 (8), 799-806. |
|
1999 Journal Article Readministration of abciximab: Interim report of the ReoPro Readministration RegistryTcheng, JE, Kereiakes, DJ, Braden, GA, Jordan, RE, Mascelli, MA, Langrall, MA and Effron, MB (1999). Readministration of abciximab: Interim report of the ReoPro Readministration Registry. American Heart Journal, 138 (1), S33-S38. doi: 10.1053/hj.1999.v138.99236 |
|
1999 Journal Article Rapport? ReplyBrener, SJ, Topol, EJ, Moliterno, DJ, Barr, LA, Burchenal, JEB, Katz, S, George, BS, Jones, AA, Cohen, ED, Gainey, PC, White, HJ, Cheek, HB, Moses, JW and Effron, MB (1999). Rapport? Reply. Circulation, 99 (25), 3324-3324. |
|
1998 Journal Article Abciximab and alveolar hemorrhage - replyCohen, SA and Effron, MB (1998). Abciximab and alveolar hemorrhage - reply. New England Journal of Medicine, 339 (25), 1862-1863. |
|
1998 Journal Article Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarctionBrener, SJ, Barr, LA, Burchenal, JEB, Katz, S, George, BS, Jones, AA, Cohen, ED, Gainey, PC, White, HJ, Cheek, HB, Moses, JW, Moliterno, DJ, Effron, MB and Topol, EJ (1998). Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation, 98 (8), 734-741. doi: 10.1161/01.CIR.98.8.734 |
|
1997 Journal Article Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarctionFuster, , Califf, RM, Chesebro, JH, Cohen, M, Comp, PC, Gheorghiade, M, Hall, J, Halperin, J, Khan, S, Kopecky, S, Langer, A, Molk, B, Moss, A, OConnor, CM, OGara, PT, Raskob, E, Sutton, J, Braunwald, E, Bell, WR, Furberg, C, Rapaport, E, DeMets, D, Goldstein, S, Richardson, D, Hillis, D, Bonow, R, Kistler, JP, Mohr, JP, Sherman, D ... Smith, C (1997). Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Lancet, 350 (9075), 389-396. |
|
1997 Journal Article The effect of digoxin on mortality and morbidity in patients with heart failurePerry, G, Brown, E, Thornton, R, Shiva, T, Hubbard, J, Reddy, KR, Doherty, JE, Cardello, FP, Fast, A, Radford, MJ, Folger, JS, Bhaskar, G, Zoble, RG, Sridharan, , Sridharan, MR, Loungani, RR, Gheorghiade, M, Hsieh, A, Tommaso, C, Mansuri, M, Guess, MA, Akhtar, S, Wagner, S, Hagan, K, McIntyre, KM, Ruble, P, Moten, M, Riley, A, Pierpont, G ... Singh, BN (1997). The effect of digoxin on mortality and morbidity in patients with heart failure. New England Journal of Medicine, 336 (8), 525-533. |
|
1996 Journal Article Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina - A randomized multicenter trialSchulman, SP, GoldschmidtClermont, PJ, Topol, EJ, Califf, RM, Navetta, FI, Willerson, JT, Chandra, NC, Guerci, AD, Ferguson, JJ, Harrington, RA, Lincoff, AM, Yakubov, SJ, Bray, PF, Bahr, RD, Wolfe, CL, Yock, PG, Anderson, HV, Nygaard, TW, Mason, SJ, Effron, MB, Fatterpacker, A, Raskin, S, Smith, J, Brashears, L, Gottdiener, P, duMee, C, Kitt, MM and Gerstenblith, G (1996). Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina - A randomized multicenter trial. Circulation, 94 (9), 2083-2089. doi: 10.1161/01.CIR.94.9.2083 |
|
1996 Journal Article The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular eventsMindlen, F, Nordaby, R, Ruiz, M, Zavala, A, Guzman, L, Martinez, F, Diaz, RR, Mackey, C, Marino, M, Romero, G, Zapata, G, Cuneo, C, Kawamura, T, Coelho, O, Massayochi, O, Braga, J, Labrunie, A, Bodanese, L, Manenti, E, Vitola, D, Nicolau, J, Amodeo, C, Armaganijan, D, Bertolami, M, Caramelli, B, Carvalho, A, Cirenza, C, Fichino, M, Franken, R ... Kennedy, JW (1996). The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Canadian Journal of Cardiology, 12 (2), 127-137. |
|
1996 Journal Article Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: A large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failureAbernathy, GT, Abrams, J, Akhtar, S, Albitar, , Amidi, M, Anand, IS, Arnold, JMO, Ashton, T, Aubrey, B, Auger, P, Babb, J, Baigrie, R, Baird, MG, Baitz, T, Barber, NC, Barbour, DJ, Barr, DM, Basu, AK, Baughman, KL, Beckham, , BekheitSaad, S, Berkson, DM, Bertoglio, M, Bessoudo, R, Beaudoin, J, Bhaskar, G, Binder, A, Bloomfield, D, Bodine, K ... Martinez, G (1996). Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: A large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. Controlled Clinical Trials, 17 (1), 77-97. |
